FindTrial
Sign In

Biological mesh for inguinal hernia repair: a prospective, multicenter, randomized, single-blind, parallel positive controlled clinical trial

Biological mesh for inguinal hernia repair: prospective, multicenter, randomized, single-blind, parallel positive controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050844
Enrollment
Unknown
Registered
2021-09-04
Start date
2018-05-09
Completion date
Unknown
Last updated
2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inguinal hernia

Interventions

Experimental group:biomedical mesh
control group:Biodesign Surgisis

Sponsors

Beijing Chao-Yang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18-75 (inclusive), gender is not limited; 2. Primary inguinal hernia; 3. The subjects voluntarily participate in the clinical trial, and the subjects (or their legal representatives) must sign the Informed Consent Form and be able to cooperate with the clinical follow-up.

Exclusion criteria

Exclusion criteria: 1. Severe heart, liver and renal insufficiency; 2. Subjects with malignant tumors requiring radiotherapy or chemotherapy; 3. Subjects who refuse to use pig-derived medical device due to religious or ethnic reasons; 4. Participated in any clinical trials and unfinished to the primary end point; 5. Other circumstances in which the researcher considers the subjects unsuitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Excellent and good rate of inguinal hernia rehabilitation;—

Countries

China

Contacts

Public ContactChen Jie

Beijing Chao-Yang Hospital, Capital Medical University

chenjiejoe@sina.com+86 13801038411

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026